vs
Side-by-side financial comparison of REED'S, INC. (REED) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.
REED'S, INC. is the larger business by last-quarter revenue ($7.5M vs $4.9M, roughly 1.5× Sensus Healthcare, Inc.). REED'S, INC. runs the higher net margin — -50.5% vs -64.1%, a 13.6% gap on every dollar of revenue. On growth, REED'S, INC. posted the faster year-over-year revenue change (-23.1% vs -62.2%). Sensus Healthcare, Inc. produced more free cash flow last quarter ($-2.4M vs $-3.9M). Over the past eight quarters, REED'S, INC.'s revenue compounded faster (-11.7% CAGR vs -31.9%).
Waddell & Reed Financial, Inc. was an American asset management and financial planning company founded in 1937 in Kansas City, Missouri. It was a publicly traded company from 1998 to 2021, and briefly had its headquarters in Overland Park, Kansas, and was planning a move back to Downtown Kansas City before the company was sold. It operated asset management and distribution subsidiaries, including Ivy Investment Management Company and Waddell & Reed Investment Management Company.
Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.
REED vs SRTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.5M | $4.9M |
| Net Profit | $-3.8M | $-3.2M |
| Gross Margin | 20.4% | 38.4% |
| Operating Margin | -46.9% | -63.8% |
| Net Margin | -50.5% | -64.1% |
| Revenue YoY | -23.1% | -62.2% |
| Net Profit YoY | 8.2% | -304.9% |
| EPS (diluted) | $-1.26 | $-0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.5M | $4.9M | ||
| Q3 25 | $7.0M | $6.9M | ||
| Q2 25 | $9.5M | $7.3M | ||
| Q1 25 | $10.0M | $8.3M | ||
| Q4 24 | $9.7M | $13.1M | ||
| Q3 24 | $6.8M | $8.8M | ||
| Q2 24 | $11.9M | $9.2M | ||
| Q1 24 | $9.6M | $10.7M |
| Q4 25 | $-3.8M | $-3.2M | ||
| Q3 25 | $-4.0M | $-943.0K | ||
| Q2 25 | $-6.0M | $-1.0M | ||
| Q1 25 | $-2.0M | $-2.6M | ||
| Q4 24 | $-4.1M | $1.5M | ||
| Q3 24 | $-4.2M | $1.2M | ||
| Q2 24 | $-3.2M | $1.6M | ||
| Q1 24 | $-1.7M | $2.3M |
| Q4 25 | 20.4% | 38.4% | ||
| Q3 25 | 17.4% | 39.4% | ||
| Q2 25 | 8.5% | 39.7% | ||
| Q1 25 | 33.9% | 52.2% | ||
| Q4 24 | 30.0% | 54.4% | ||
| Q3 24 | 18.0% | 59.3% | ||
| Q2 24 | 32.3% | 58.7% | ||
| Q1 24 | 35.6% | 62.5% |
| Q4 25 | -46.9% | -63.8% | ||
| Q3 25 | -58.3% | -37.3% | ||
| Q2 25 | -60.8% | -26.6% | ||
| Q1 25 | -17.4% | -31.7% | ||
| Q4 24 | -37.6% | 13.2% | ||
| Q3 24 | -46.5% | 16.9% | ||
| Q2 24 | -5.6% | 21.5% | ||
| Q1 24 | -6.8% | 27.1% |
| Q4 25 | -50.5% | -64.1% | ||
| Q3 25 | -56.6% | -13.7% | ||
| Q2 25 | -63.5% | -14.2% | ||
| Q1 25 | -20.3% | -30.8% | ||
| Q4 24 | -42.3% | 11.8% | ||
| Q3 24 | -61.5% | 13.7% | ||
| Q2 24 | -27.1% | 17.4% | ||
| Q1 24 | -17.4% | 21.3% |
| Q4 25 | $-1.26 | $-0.19 | ||
| Q3 25 | $-0.48 | $-0.06 | ||
| Q2 25 | $-0.13 | $-0.06 | ||
| Q1 25 | $-0.04 | $-0.16 | ||
| Q4 24 | $-3.73 | $0.10 | ||
| Q3 24 | $-4.91 | $0.07 | ||
| Q2 24 | $-0.77 | $0.10 | ||
| Q1 24 | $-0.40 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $22.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $9.2M | $48.1M |
| Total Assets | $23.3M | $53.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $22.1M | ||
| Q3 25 | — | $24.5M | ||
| Q2 25 | — | $22.2M | ||
| Q1 25 | — | $19.1M | ||
| Q4 24 | — | $22.1M | ||
| Q3 24 | — | $22.6M | ||
| Q2 24 | — | $19.0M | ||
| Q1 24 | — | $14.7M |
| Q4 25 | $9.2M | $48.1M | ||
| Q3 25 | $2.8M | $51.2M | ||
| Q2 25 | $1.7M | $52.1M | ||
| Q1 25 | $4.7M | $53.0M | ||
| Q4 24 | $6.6M | $55.8M | ||
| Q3 24 | $-22.0M | $54.1M | ||
| Q2 24 | $-23.8M | $52.9M | ||
| Q1 24 | $-20.7M | $51.2M |
| Q4 25 | $23.3M | $53.0M | ||
| Q3 25 | $19.9M | $58.3M | ||
| Q2 25 | $23.7M | $58.9M | ||
| Q1 25 | $24.5M | $60.2M | ||
| Q4 24 | $25.1M | $62.2M | ||
| Q3 24 | $15.0M | $59.9M | ||
| Q2 24 | $18.7M | $58.2M | ||
| Q1 24 | $19.3M | $57.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.8M | $-2.2M |
| Free Cash FlowOCF − Capex | $-3.9M | $-2.4M |
| FCF MarginFCF / Revenue | -52.0% | -47.9% |
| Capex IntensityCapex / Revenue | 1.1% | 3.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-17.3M | $332.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.8M | $-2.2M | ||
| Q3 25 | $-2.8M | $2.3M | ||
| Q2 25 | $-5.0M | $3.1M | ||
| Q1 25 | $-5.4M | $-2.7M | ||
| Q4 24 | $-3.9M | $-827.0K | ||
| Q3 24 | $1.1M | $4.0M | ||
| Q2 24 | $-912.0K | $4.2M | ||
| Q1 24 | $-2.4M | $-8.2M |
| Q4 25 | $-3.9M | $-2.4M | ||
| Q3 25 | $-2.9M | $2.3M | ||
| Q2 25 | $-5.1M | $3.1M | ||
| Q1 25 | $-5.4M | $-2.7M | ||
| Q4 24 | $-4.0M | $-1.1M | ||
| Q3 24 | $1.0M | $3.6M | ||
| Q2 24 | $-924.0K | $4.2M | ||
| Q1 24 | $-2.4M | $-8.4M |
| Q4 25 | -52.0% | -47.9% | ||
| Q3 25 | -41.5% | 33.3% | ||
| Q2 25 | -53.2% | 42.2% | ||
| Q1 25 | -54.2% | -32.2% | ||
| Q4 24 | -40.8% | -8.6% | ||
| Q3 24 | 15.3% | 40.9% | ||
| Q2 24 | -7.8% | 45.8% | ||
| Q1 24 | -25.1% | -79.0% |
| Q4 25 | 1.1% | 3.2% | ||
| Q3 25 | 1.4% | 0.1% | ||
| Q2 25 | 0.2% | 0.4% | ||
| Q1 25 | 0.7% | 0.1% | ||
| Q4 24 | 1.0% | 2.3% | ||
| Q3 24 | 0.3% | 3.8% | ||
| Q2 24 | 0.1% | 0.0% | ||
| Q1 24 | 0.2% | 2.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.53× | ||
| Q3 24 | — | 3.25× | ||
| Q2 24 | — | 2.62× | ||
| Q1 24 | — | -3.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
REED
Segment breakdown not available.
SRTS
| Products | $2.8M | 57% |
| Other | $2.1M | 43% |
